Premium
In vitro basophil histamine‐releasing activity of circulating IgG1 and IgG4 autoanti‐IgE antibodies from asthma patients and the demonstration that anti‐IgE modulates allergen‐induced basophil activation
Author(s) -
SHAKIB F.,
SMITH S. J.
Publication year - 1994
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/j.1365-2222.1994.tb00230.x
Subject(s) - basophil , immunoglobulin e , histamine , immunology , allergen , antibody , basophil activation , allergy , chemistry , medicine , pharmacology
Summary In this study we have examined the relationship between the in vitro basophil histamine‐releasing activity of human IgG anti‐IgE, isolated as euglobulin fractions from sera of asthmatic patients, and its IgG1/IgG4 subclass distribution. In particular, we have investigated whether IgG anti‐IgE modulates allergen‐induced basophil activation. The study has revealed that only a small proportion of IgG anti‐IgE samples triggered histamine release from basophils of an asthmatic individual (4/21; 19%), a hay fever sufferer (4/10; 40%) and a healthy person (7/21; 33%). The basophil histamine‐releasing activity of IgG anti‐IgE did not seem to be determined by the IgG1/IgG4 subclass composition of the IgG anti‐IgE preparation used. Furthermore, we have demonstrated that autoanti‐IgE antibodies modulate allergen‐induced basophil histamine release. The three modulatory effects exerted by IgG anti‐IgE antibodies on allergen‐triggered basophil activation (i.e. additive, synergistic and blocking) were not dependent on the subclass nature of IgG anti‐IgE or the use of histamine‐releasing anti‐IgE preparations. Our data suggest that IgG anti‐IgE antibodies in asthma patients may consist of two functionally distinct subpopulations: those which up‐regulate (pro‐allergic) and those which down‐regulate (anti‐allergic) the allergic release of mediators from mast cells and basophils.